For several decades, hormone therapy and its risk-to-benefit ratio have been a controversial topic within the scientific community. First published in 2002, reports from the Women’s Health Initiative (WHI) presented data on the complicated benefits and potential adverse events associated with menopausal hormone therapy. Prior to this, estrogen therapy was put into question due to its association with an increased risk of endometrial hyperplasia and cancer, however, it subsequently rose to popularity again following the discovery that the addition of progesterone was able to minimize the associated risks.
With burgeoning research in the field of longevity and anti-aging medicine, as well as a growing understanding of disease pathophysiology, integrative medicine has witnessed many recent developments; from advances in sirtuin therapy to novel combinatorial regenerative applications of stem cells, the field continues to evolve at lightning speed. Staying clinically current and abreast of all of the latest education is imperative for clinicians looking to maintain an advantage and deliver optimal patient care. At the largest event in Anti-Aging Medicine, the 27th Annual World Congress, experts and industry leaders will delve into the most recent clinical data, newly discovered therapies, and emerging scientific advances. Providing a comprehensive anti-aging industry update, the three-day event will focus on delivering world-class education opportunities for physicians leading the mission to redefine modern medicine.
From the latest cannabidiol guidelines to new updates in peptide and hormone therapy strategies, attendees will have the opportunity to explore the latest topics in integrative medicine through an expertly curated agenda covering the latest developments within the field. Attendees of the 27th Annual World Congress will experience a combination of unique programming, a diverse audience of thousands of fellow medical professionals, and a collaborative learning environment through which to learn how to implement the latest education into practice and help enhance the landscape of modern medicine.
A growing understanding of the intricacies of thyroid health, hormonal imbalances and therapies, as well as advancements in other facets of the burgeoning field of clinical endocrinology have drawn increased attention to novel treatment modalities and their potential to relieve –and even prevent – many symptoms of the aging process. To optimize treatment strategies and patient health outcomes, it is increasingly important for clinicians to stay up-to-date on the latest developments in hormone health. At one of our most popular events, the Bioidentical Hormone Replacement Therapy Symposium, a panel of experts will review the most recent and relevant research available, analyze the medical evidence surrounding hormone therapies, and delve into strategies for safely and effectively merging them into clinical practice. From thyroid optimization to growth hormone deficiency, attendees will have the opportunity to explore the most clinically current topics in the field through a series of expert-led sessions curated to provide a comprehensive overview of the latest updates in endocrinology.